Cargando…
Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
BACKGROUND: Several recent studies have shown that screen detection remains an independent prognostic factor after adjusting for disease stage at presentation. This study compares the molecular characteristics of screen-detected with symptomatic breast cancers to identify if differences in tumour bi...
Autores principales: | Dawson, S J, Duffy, S W, Blows, F M, Driver, K E, Provenzano, E, LeQuesne, J, Greenberg, D C, Pharoah, P, Caldas, C, Wishart, G C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768460/ https://www.ncbi.nlm.nih.gov/pubmed/19773756 http://dx.doi.org/10.1038/sj.bjc.6605317 |
Ejemplares similares
-
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012) -
Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer
por: Ali, A M G, et al.
Publicado: (2011) -
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010) -
Astronomical algorithms for automated analysis of tissue protein expression in breast cancer
por: Ali, H R, et al.
Publicado: (2013) -
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
por: Wishart, G C, et al.
Publicado: (2008)